Susan H Woulfe

Address:

255 E Main St, Evansville, WI 53536

Phone:

608 882-6656

VIN:

JM1BK32F471616035

Make:

MAZDA

Model:

MAZDA3

Year:

2007

US Patent:

20050042219, Feb 24, 2005

Filed:

Dec 5, 2003

Appl. No.:

10/728420

Inventors:

Susan Woulfe - Woodbury MN, US
Rita Jain - Roslyn Harbor NY, US
Aimee Burr - Chicago IL, US

International Classification:

A61K039/395
A61K031/525

US Classification:

424145100, 514251000

Abstract:

The present invention provides a combination therapeutic composition useful in modulating, treating and/or preventing inflammatory diseases. The therapeutic composition includes antibody Fab′ fragment CDP870 that is specific for antigenic determinants of tumor necrosis factor alpha and at least one Disease Modifying Anti-Rheumatic Disease drug such as methotrexate or sulfasalazine. The therapeutic composition can be administered to either a human or animal subject in single or multiple doses over time in the treatment of rheumatoid arthritis, Crohn's Disease or any other inflammatory disease.

US Patent:

20220189632, Jun 16, 2022

Filed:

Oct 3, 2019

Appl. No.:

17/436743

Inventors:

- St. Paul MN, US
Gilles J. Benoit - Minneapolis MN, US
Peter O. Olson - Andover MN, US
Tyler W. Olson - Woodbury MN, US
Himanshu Nayar - St. Paul MN, US
Frederick J. Arsenault - Stillwater MN, US
Nicholas A. Johnson - Burnsville MN, US
Susan L. Woulfe - Woodbury MN, US
Mark A. Tomai - Hudson WI, US

International Classification:

G16H 50/20
G16H 50/50
G16H 20/10
A61B 5/00
A61B 5/0205
A61B 5/021
A61B 5/024
A61B 5/145
A61M 16/00

Abstract:

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for selecting settings for a treatment of a patient. In one aspect, the method comprises repeatedly performing the following: i) selecting a configuration of input settings for providing a treatment to a patient based on a causal model that measures current causal relationships between input settings and effects of treatments on the patient; ii) receiving a measure of an effect of the treatment on the patient; and iii) adjusting, based on the measure of the effect of the treatment on the patient, the causal model.

US Patent:

20220178899, Jun 9, 2022

Filed:

Oct 3, 2019

Appl. No.:

17/436770

Inventors:

- St. Paul MN, US
Gilles J. Benoit - Minneapolis MN, US
Peter O. Olson - Andover MN, US
Tyler W. Olson - Woodbury MN, US
Himanshu Nayar - St. Paul MN, US
Frederick J. Arsenault - Stillwater MN, US
Nicholas A. Johnson - Woodbury MN, US
Susan L. Woulfe - Woodbury MN, US
Mark A. Tomai - Hudson WI, US

International Classification:

G01N 33/15
G05B 13/04
B01J 19/00

Abstract:

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for optimizing a process of manufacturing a biologic pharmaceutical. In one aspect, the method comprises repeatedly performing the following: i) selecting a configuration of input settings for manufacturing a batch of a biologic pharmaceutical based on a causal model that measures current causal relationships between input settings and a measure of a quality of batches of the biological pharmaceutical; ii) determining a measure of the quality of a batch of the biological pharmaceutical manufactured using the configuration of input settings; and iii) adjusting, based on the measure of the quality of the batch of the biological pharmaceutical, the causal model.

US Patent:

20220180979, Jun 9, 2022

Filed:

Oct 28, 2019

Appl. No.:

17/436840

Inventors:

- St. Paul MN, US
Gilles J. Benoit - Minneapolis MN, US
Peter O. Olson - Andover MN, US
Tyler W. Olson - Woodbury MN, US
Himanshu Nayar - St. Paul MN, US
Frederick J. Arsenault - Stillwater MN, US
Nicholas A. Johnson - Woodbury MN, US
Susan L. Woulfe - Woodbury MN, US
Mark A. Tomai - Hudson WI, US

International Classification:

G16H 10/20
G16H 50/70

Abstract:

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for designing a clinical trial. In one aspect, the method comprises repeatedly performing the following: i) selecting, from a population of patients, patients for being treated with the treatment using a configuration of input settings, wherein the configuration is selected based on a causal model that measures current causal relationships between input settings and a measure of success of the clinical trial; ii) determining the measure of success of the clinical trial for which patients were selected using the certain configuration of input settings; and iii) adjusting, based on the measure of success of the clinical trial, the causal model.